BioSpace News Archive

Acquisition is Expected to Expand J&J’s Consumer Portfolio of Science-based Dermocosmetic Beauty Products [23-October-2018] NEW BRUNSWICK, N.J. , Oct. 23, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that they have agreed with Ci:z Holdings Co., Ltd. (TYO: 4924) (the “Company”), a Japanese company focused on the marketing, development and

The American College of Prosthodontists’ 2018 Annual Session will be in Charm City Oct. 31-Nov.3

CoA Assembles Scientific Advisory Board with Lead Investigator Suzanne Jackowski and Additional Experts in Neurodegeneration and Inborn Errors of Metabolism

Researchers in Toronto, Calgary and Vancouver use genetics to find more personalized treatment options for prostate cancer patients

New buy and build investment in leading healthcare governance, risk and compliance SaaS platform

Lead candidate to treat the genetic cause of Dravet Syndrome expected to reach clinic by 2020

The Company now occupies more than 60,000 sq. ft. of laboratory and office space at the Durham, North Carolina, facility

Court Rules Edwards Lifesciences’ Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany

Brings Total Company Investment in Nebraska to $340 Million in Two Years

CROMSOURCE announced today the appointment of its Regulatory Services Department Director, Mr. David R. Dills, and the expansion of its Regulatory Services portfolio.